🇮🇳IN
Sign In
NE

NEULANDLAB

NSE

Neuland Laboratories Limited

₹19,424.00

-91.00(-0.47%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-end

This is the flow into the whole Healthcare sector, not into NEULANDLAB. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

NEULANDLAB exposure summary

Neuland Laboratories Limited reports a single business segment, Manufacturing of Active Pharmaceuticals. Neuland Laboratories Limited is a constituent of 5 indices, with its largest weights in NIFTY Smallcap 100 (1.37%), S&P BSE 500 (0.09%), NIFTY 500 (0.09%). 11 exchange-traded funds hold the stock.

Index memberships5
ETFs holding11

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer